Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | GSR | P00390 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | BLM | P54132 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11808205 | 0.95 | ALDH1A1 (0.47) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL7762345 | 0.94 | ALDH1A1 (0.46) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL9576103 | 0.94 | ALDH1A1 (0.46) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL9653991 | 0.94 | ALDH1A1 (0.46) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL10684907 | 0.94 | ALDH1A1 (0.46) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL1275468 | 0.91 | HSPA5 (0.50) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL9507166 | 0.88 | ALDH1A1 (0.53) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL1275511 | 0.85 | HSPA5 (0.48) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL1274849 | 0.85 | HSPA5 (0.48) | ALDH1A1TSHRLMNAGAAGSR | |
| SCHEMBL1275458 | 0.85 | HSPA5 (0.48) | ALDH1A1TSHRLMNAGAAGSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1179555-B1 | 1:1 Monoadducts from hydroxy(meth)acrylates and diisocyanates having low monomer content and process for their preparation | DEGUSSA (DE) | 2005-04-27 | — | — | EP | claimed |
| US-6548696-B2 | Useful as starting material for acrylic or isocyanate-functionalized crosslinker, a bonding agent for coatings and adhesives, and a linker for solid-phase synthesis of oligonucleotides, polynucleotides, or peptides | DEGUSSA AG (DE) | 2003-04-15 | — | — | US | claimed |
| US-20020049349-A1 | Low monomer 1:1-monoadducts from hydroxy (meth) acrylates and diisocyanates and a process for their manufacture | DEGUSSA AG (DE) | 2002-04-25 | — | — | US | claimed |
| EP-1179555-A1 | 1:1 Monoadducts from hydroxy(meth)acrylates and diisocyanates having low monomer content and process for their preparation | Degussa AG (DE) | 2002-02-13 | — | — | EP | claimed |
| EP-4547726-A1 | SILICONE URETHANE (METH)ACRYLATES AND THEIR USE IN COATING COMPOSITIONS | Evonik Operations GmbH (DE) | 2025-05-07 | — | — | EP | disclosed |
| US-12173111-B2 | Composition comprising polyesters for additive manufacturing | EVONIK OPERATIONS GMBH (DE) | 2024-12-24 | — | — | US | disclosed |
| US-20240101752-A1 | SILICONE URETHANE (METH)ACRYLATES AND THEIR USE IN 3D PRINTING RESINS AND COATING COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2024-03-28 | — | — | US | disclosed |
| WO-2024002742-A1 | SILICONE URETHANE (METH)ACRYLATES AND THEIR USE IN COATING COMPOSITIONS | EVONIK OPERATIONS GMBH (DE) | 2024-01-04 | — | — | WO | disclosed |
| EP-4277942-A1 | SILICONE URETHANE (METH)ACRYLATES AND THEIR USE IN 3D PRINTING RESINS AND COATING COMPOSITIONS | Evonik Operations GmbH (DE) | 2023-11-22 | — | — | EP | disclosed |
| EP-4076959-B1 | ADDITIVE MANUFACTURING PROCESS WITH A COMPOSITION COMPRISING POLYESTERS | EVONIK OPERATIONS GMBH (DE) | 2023-09-27 | — | — | EP | disclosed |
| CN-116724067-A | Silicone urethane (meth) acrylates and their use in 3D printing resins and coating compositions | 赢创运营有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-115943049-A | Method of making an additive using a composition comprising a polyester | 赢创运营有限公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-2367864-A1 | LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS | Evonik Degussa GmbH (DE) | 2011-09-28 | — | — | EP | disclosed |
| WO-2010115644-A1 | METHOD FOR PRODUCING 1:1 ADDUCTS HAVING A LOW MONOMER CONTENT FROM HYDROXYALKYL(METH)ACRYLATES AND DIISOCYANATES | EVONIK DEGUSSA GMBH (DE) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010072439-A1 | LOW MONOMER 1 : 1 MONOADDUCTS OF REACTIVE OLEFINIC COMPOUNDS AND DIISOCYANATES USING INSERTABLE INHIBITORS | EVONIK DEGUSSA GMBH (DE) | 2010-07-01 | — | — | WO | disclosed |
| EP-1179555-B1 | 1:1 Monoadducts from hydroxy(meth)acrylates and diisocyanates having low monomer content and process for their preparation | DEGUSSA (DE) | 2005-04-27 | — | — | EP | disclosed |
| US-6548696-B2 | Useful as starting material for acrylic or isocyanate-functionalized crosslinker, a bonding agent for coatings and adhesives, and a linker for solid-phase synthesis of oligonucleotides, polynucleotides, or peptides | DEGUSSA AG (DE) | 2003-04-15 | — | — | US | disclosed |
| US-20020049349-A1 | Low monomer 1:1-monoadducts from hydroxy (meth) acrylates and diisocyanates and a process for their manufacture | DEGUSSA AG (DE) | 2002-04-25 | — | — | US | disclosed |
| EP-1179555-A1 | 1:1 Monoadducts from hydroxy(meth)acrylates and diisocyanates having low monomer content and process for their preparation | Degussa AG (DE) | 2002-02-13 | — | — | EP | disclosed |
| US-3960758-A | SULFUR-CONTAINING PHENOL | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049349-A1 | Low monomer 1:1-monoadducts from hydroxy (meth) acrylates and diisocyanates and a process for their manufacture | NOS1, PAM, ACP1 | ALDH1A1 1560/4885TSHR 2344/4885LMNA 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.